tiprankstipranks
Evogene Ltd. Reports Mid-Year Financial Dip
Company Announcements

Evogene Ltd. Reports Mid-Year Financial Dip

Evogene (EVGN) has released an update.

Stay Ahead of the Market:

Evogene Ltd. has released its unaudited interim consolidated financial statements, revealing a decrease in cash and cash equivalents from $20,772 thousand on December 31, 2023, to $9,484 thousand by June 30, 2024. The company’s total current assets diminished from $34,469 thousand to $25,774 thousand in the same period, while overall liabilities and shareholders’ equity also saw a decline.

For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles